SOURCE: NuGene International, Inc.

NuGene International, Inc.

July 20, 2015 07:05 ET

NuGene International Inc. Secures $301,450 Product Purchase Reorder From Leading Existing Distributor and Also Announces New Distributor With Initial Orders Exceeding $71,000

IRVINE, CA--(Marketwired - Jul 20, 2015) - NuGene International, Inc. ("NuGene") (OTCQB: NUGN), a developer, manufacturer and marketer of advanced skin and hair care lines utilizing adipose derived human stem cells and stem cell media, secured a product purchase reorder in June 2015 from existing distributor, Glass Jar, Inc., totaling $301,450. NuGene delivered $225,997 of the product ordered in June with the balance scheduled to deliver in July.

"We are very excited to be carrying the NuGene anti-aging skin care and hair rejuvenation lines. We have finally found a product whose performance actually matches our customers' expectations," said Dr. Nima Shemirani, medical director of Glass Jar Inc.

During June 2015, NuGene also secured a new account from Dr. Alexander Duka, CEO of http://myhealth.market with an initial purchase totaling $38,407. "I have been intrigued by human stem cell technology for years and I have finally found a product backed by science. I have been absolutely amazed how fast NuGene has been selling and it is quickly becoming one of my best selling product lines," stated Dr. Duka. In July, Dr. Duka submitted a second order for approximately $33,000 worth of NuGene product.

"Typically the cosmetics business is seasonal with stronger sales developing in Q3 and Q4. We are very encouraged by the demand for our products this early in the season," said Dr. Fady Elias, Director of Professional Business Development for NuGene. "Our whitepaper studies and marketing strategy have significantly lowered our barriers to entry and we will continue to pursue this strategy in the future."

About NuGene, Inc.
NuGene International, Inc. specializes in developing, manufacturing and marketing proprietary regenerative cosmeceutical and pharmaceutical products based on adipose derived human stem cell and human stem cell media. The US Department of Health and Human Services calls regenerative medicine the "next evolution of medical treatments." The regenerative medical market which includes cosmeceuticals and pharmaceuticals was estimated at $7.2 Billion in the US in 2014 and is expected to rapidly grow in the coming years according to RNCOS Business Consultancy Services Global Cosmeceuticals Market report. NuGene's cosmeceutical and pharmaceutical products are based on proprietary stem cell based regenerative formulations derived from non-controversial, adult human stem cell derived media obtained from adipose tissue. NuGene's exclusive products combine its in-house advancements, proprietary technologies, and patent pending formulations. The company has four patents pending covering 15 unique applications. NuGene's goal is to leverage its knowledge and expertise to develop age defying cosmeceutical skincare and hair care products in addition to pharmaceutical products based on the same regenerative science platform.

About Glass Jar
Glass Jar Inc., based out of San Diego, CA, distributes skin and hair care products that utilize scientific breakthroughs including stem cell based technologies. Our Medical Director, Dr. Nima Shemirani is a Board Certified head and neck surgeon who specializes in facial plastic surgery and ENT (ear, nose, and throat) procedures.

About Myhealth.Market
MyHealth.Market is a visionary health and beauty store based out of Austin, Texas. We strive to make a difference whether big or small in all of our customers lives. Our online collection features an ever increasing amount of classic and emerging brands across a broad range of product categories including skin care, nutritional, anti-aging and immune system health products.

Forward Looking Statements
 
This document contains "forward-looking statements," statements related to future, not past, events. In this context, forward-looking statements often address NuGene's expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," or "target." Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about our current and future sales, planned operations, marketing activities and other operational, sales and financial plans. These may include our ability to convert pre-order commitments/wins into orders; timing of planned and anticipated product deliveries; the price we realize on orders since commitments/wins are stated at list prices; customer actions or developments such as customer returns and other factors that may affect the level of demand and performance of the major industries and customers we serve; the impact of regulation and regulatory, investigative and legal proceedings and legal compliance risks, including the impact of regulation and litigation; adverse market conditions, timing of and ability to obtain required regulatory approvals, or other factors relating to us; the impact of potential information technology or data security breaches; and the other factors that are described in "Risk Factors" in NuGene's Annual Report on Form 10-K for the year ended December 31, 2014. These or other uncertainties may cause our actual future results to be materially different than those expressed in our forward-looking statements. We do not undertake to update our forward-looking statements. This document also contains non-GAAP financial information. Management uses this information in its internal analysis of results and believes that this information may be informative to investors in gauging the quality of our financial performance, identifying trends in our results and providing meaningful period-to-period comparisons.

Contact Information

  • Investor/ Media Relations:
    Jay Goth
    951.704.6792